Whether you're hitting the links, enjoying the trails, or keeping up with your kids' busy schedules, excess weight can hold you back from fully embracing the lifestyle you've built here
Glutathione + Methylene Blue , , , ,
It has demonstrated that dual agonism (GLP-1 + GIP) can significantly outperform earlier GLP-1 therapies
doi: 10.3389/fmed.2022.875430 Summary Keywords glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin based therapy, glucose-depent insulinotropic peptide (GIP), dual agonists, tirzepatide, type 2 diabetes Citation Gallwitz B (2022) Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity
FDA-approved high-dose sublingual glutathione vials, as effective as IV with no clinic visits